Novo Nordisk’s experimental obesity drug CagriSema shows blood pressure benefitsÂ
COPENHAGEN, Nov 6 (Reuters) – Novo Nordisk (NOVOb.CO), opens new tab said on Thursday its experimental obesity drug…
Novo Nordisk, Lilly strike pricing deal with Trump for weight-loss drugs
Starter doses of weight‑loss pills, if approved, will cost $149 per monthPrice for injectables would fall to $245…